Alcon (ALC) Receives a Sell from Bank of America Securities
Bank of America Securities analyst Julien Ouaddour maintained a Sell rating on Alcon today and set a price target of CHF60.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ouaddour covers the Healthcare sector, focusing on stocks such as Smith & Nephew, Koninklijke Philips N.V., and Alcon. According to TipRanks, Ouaddour has an average return of 18.8% and a 68.97% success rate on recommended stocks.
Alcon has an analyst consensus of Moderate Buy, with a price target consensus of CHF74.10.
Based on Alcon’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of CHF2.61 billion and a net profit of CHF237 million. In comparison, last year the company earned a revenue of CHF2.45 billion and had a net profit of CHF263 million
Read More on ALC:
Disclaimer & DisclosureReport an Issue
- Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating
- Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion
- Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation
- Alcon reports Q4 core EPS 78c, consensus 79c
- Alcon says has undertaken operational improvements
